Lilly expands migraine offerings after FDA approval 14-Oct-2019 By Ben Hargreaves US FDA gives marketing authorization to Lilly’s oral medication for the acute treatment of migraines in adult patients, adding to its Emgality approval almost exactly a year ago.
